MF
GILD icon

MHI Funds’s Gilead Sciences GILD Stock Holding History

MHI Funds’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2.11M Sell
28,175
-15,961
-36% -$1.1M 6.07% 1
2019
Q4 		$2.87M Sell
44,136
-3,148
-7% -$205K 3.65% 6
2019
Q3 		$3M Sell
47,284
-686
-1% -$44.8K 3.49% 2
2019
Q2 		$3.24M Buy
+47,970
New +$3.16M 3.79% 1

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

MHI Funds's GILD Position: Q1 2020 in Review

MHI Funds reduced its Gilead Sciences (GILD) stake by 36% in Q1 2020, selling an estimated $1.1M and leaving 28,175 shares worth $2.11M. The position accounts for 6.07% of the portfolio, ranked #1.

MHI Funds first reported a position in GILD in Q2 2019 and has held it in 4 quarters since. The position peaked at $3.24M in Q2 2019. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • MHI Funds held 28,175 shares of Gilead Sciences worth $2.11M as of Q1 2020.
  • MHI Funds sold 15,961 Gilead Sciences shares in Q1 2020, an estimated $1.1M.
  • Gilead Sciences made up 6.07% of MHI Funds's portfolio in Q1 2020, its #1 holding.
  • MHI Funds first reported a position in Gilead Sciences in Q2 2019 and has held it in 4 quarters since.
  • MHI Funds's Gilead Sciences position peaked at $3.24M in Q2 2019.
  • 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on MHI Funds's 13F filing for Q1 2020, filed 5 May 2020.